Severe pulmonary hypertension and chronic obstructive pulmonary disease

被引:452
|
作者
Chaouat, A [1 ]
Bugnet, AS [1 ]
Kadaoui, N [1 ]
Schott, R [1 ]
Enache, I [1 ]
Ducoloné, A [1 ]
Ehrhart, M [1 ]
Kessler, R [1 ]
Weitzenblum, E [1 ]
机构
[1] Hop Hautepierre, Serv Pneumol, F-67098 Strasbourg, France
关键词
chronic obstructive pulmonary disease; pulmonary artery pressure; pulmonary hypertension; respiratory function tests;
D O I
10.1164/rccm.200401-006OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Severe pulmonary hypertension occurs occasionally in patients with chronic obstructive pulmonary disease (COPD), but no detailed description of these patients is available. Objectives: To identify and characterize patients with COPD and severe pulmonary hypertension. Methods: Retrospective study of 27 patients with COPD with severe pulmonary hypertension (pulmonary artery mean pressure [Ppa], >= 40 mm Hg) among 998 patients who underwent right heart catheterization between 1990 and 2002 as part of a workup for chronic respiratory failure during a period of disease stability. Results: Of the 27 patients, 16 had another disease capable of causing pulmonary hypertension. The remaining I I (I I of 998, 1.1%) patients had COPD as the only cause of pulmonary hypertension, with a median Ppa of 48 mm Hg (interquartile range, 46-50). They had an unusual pattern of cardiopulmonary abnormalities with mild to moderate airway obstruction, severe hypoxemia, hypocapnia, and a very low diffusing capacity for carbon monoxide (p < 0.01 compared with a control group of patients with COPD). Exertional dyspnea was more severe (p < 0.01) and survival was shorter (p = 0.0026) than in the control subjects. Conclusions: Severe pulmonary hypertension is uncommon in patients with COPD. When it occurs, another cause must be sought. COPD with severe pulmonary hypertension and no other possible cause shares features with pulmonary vascular diseases, such as idiopathic pulmonary hypertension.
引用
收藏
页码:189 / 194
页数:6
相关论文
共 50 条
  • [31] Outpatient pulmonary rehabilitation in severe chronic obstructive pulmonary disease
    White, RJ
    Rudkin, ST
    Ashley, J
    Stevens, VAJ
    Burrows, S
    Pounsford, JC
    Cratchley, G
    Ambler, NR
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON, 1997, 31 (05): : 541 - 545
  • [32] Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension
    Yakovleva, Olga
    Masloiid, Tatiana
    Klekot, Alexandra
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [33] Treating Hypertension in Chronic Obstructive Pulmonary Disease
    Finks, Shannon W.
    Rumbak, Mark J.
    Self, Timothy H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (04): : 353 - 363
  • [34] PULMONARY HYPERTENSION IN CHRONIC OBSTRUCTIVE LUNG DISEASE
    NIDEN, AH
    BURROWS, B
    RABINOWICZ, M
    DUCHELLE, RA
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1964, 90 (02): : 318 - &
  • [35] Chronic obstructive pulmonary disease and severe pneumonia
    Yamaya, Mutsuo
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2012, 12 (02) : 177 - 179
  • [36] The management of severe chronic obstructive pulmonary disease
    Calverley, PMA
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON, 1999, 33 (06): : 516 - 521
  • [37] Antibiotics for severe chronic obstructive pulmonary disease
    Knaus, WA
    Scheid, WM
    LANCET, 2001, 358 (9298): : 2013 - 2013
  • [38] Rehabilitation in severe chronic obstructive pulmonary disease
    Wedzicha, JA
    LANCET, 1996, 348 (9042): : 1661 - 1661
  • [39] The role of vitamin D in chronic obstructive pulmonary disease with pulmonary hypertension
    Li, Mengxi
    PULMONARY CIRCULATION, 2023, 13 (04)
  • [40] Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
    Nicholas W Morrell
    Matthew A Higham
    Peter G Phillips
    B Haleema Shakur
    Paul J Robinson
    Ray J Beddoes
    Respiratory Research, 6